grantDOI: https://doi.org/10.48105/CTF.CTF-2023-05-003.pc.gr.172001 studyName: Developing a thrombopoietin inhibitor to treat NF2 hearing loss and schwannoma growth dataStatus: Under Embargo initiative: Drug Discovery Initiative Registered Reports studyLeads: Lawrence Sherman studyStatus: Active diseaseFocus: Neurofibromatosis type 2 institutions: Oregon Health and Science University fundingAgency: CTF manifestation: Schwannoma studyFileviewId: syn61831977 syn61831971 syn61832057 syn61831972 syn61831977 syn61831973
Drop files to upload
Developing a thrombopoietin inhibitor to treat NF2 hearing loss and schwannoma growth page is loading…